4.5 Review

Is there a future for a Staphylococcus aureus vaccine?

Journal

VACCINE
Volume 30, Issue 19, Pages 2921-2927

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2011.11.006

Keywords

Staphylococcus aureus; Bacterial vaccine; Cell mediated immunity; IL-17; Th17

Ask authors/readers for more resources

Multiple attempts to develop a vaccine to prevent Staphylococcus aureus infections have failed. To date, all have been based upon the development of opsonic antibodies. New information suggests that cell mediated immunity may be critical for protection against S. aureus infections. The arm of the immune system that provides the protection contains the Th17/IL-17 axis. Th17 cells release IL-17, which are important for mobilization and activation of neutrophils. Naturally, antibodies aid the neutrophils in the uptake and killing of staphylococci, but immune globulin does not seem to be sufficient to afford protection. New approaches that focus on Th17/IL-17 may allow for the development of a successful S. aureus vaccine. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available